Funder: National Multiple Sclerosis Society
Due Dates (Anticipated): November 2025 (Pre-applications open) | January 2026 (Pre-application deadline) | January 2026 (Full application deadline)
Funding Amounts: Up to $800,000 in direct costs per project; project duration 1–2 years.
Summary: Funds late-stage preclinical and translational research partnerships to accelerate therapeutic development for progressive multiple sclerosis.
Key Information: Open to both for-profit and non-profit organizations worldwide; strict pharmaceutical-quality standards required.